# Analgesic Efficacy of Transmucosal Fentanyl for Breakthrough Pain Caused by Interventional Gastrostomy

> **NCT02869321** · PHASE4 · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 20 (actual)

## Conditions studied

- Gastrostomy
- Breakthrough Pain
- Upper Aerodigestive Tract Neoplasms

## Interventions

- **DRUG:** Fentanyl
- **DRUG:** Morphine Sulfate
- **DRUG:** Fentanyl placebo
- **DRUG:** Morphine Sulfate placebo
- **PROCEDURE:** Gastrostomy

## Key facts

- **NCT ID:** NCT02869321
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02869321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02869321, "Analgesic Efficacy of Transmucosal Fentanyl for Breakthrough Pain Caused by Interventional Gastrostomy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02869321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*